Page last updated: 2024-10-31

midodrine and Autoimmune Diseases of the Nervous System

midodrine has been researched along with Autoimmune Diseases of the Nervous System in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Autoimmune Diseases of the Nervous System: Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components (e.g., myelin) and may be limited to the central nervous system (e.g., MULTIPLE SCLEROSIS) or the peripheral nervous system (e.g., GUILLAIN-BARRE SYNDROME).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, SK1
Morillo, C1
Vernino, S1

Other Studies

1 other study available for midodrine and Autoimmune Diseases of the Nervous System

ArticleYear
Autoimmune autonomic ganglionopathy with late-onset encephalopathy.
    Autonomic neuroscience : basic & clinical, 2009, Mar-12, Volume: 146, Issue:1-2

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Autoantibodies; Autoantigens; Autoimmune Diseases of the Ne

2009